fluorexon and glycine
fluorexon has been researched along with glycine in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bacellar, FC; Perren, SM; Rahn, BV; Trapp, L | 1 |
| Boehme, P; Gordeuk, VR; John, C; Loyevsky, M; Sacci, JB; Weglicki, W | 1 |
| Hasinoff, BB | 1 |
| Hasinoff, BB; Schroeder, PE | 1 |
| Cho, MJ; Erickson, BW; Riché, EL | 1 |
| Chiu, W; Goodwin, JT; Khant, HA; Li, F; Li, KC; Li, Z; O'Neill, BE; Qin, G; Xia, R | 1 |
Other Studies
6 other study(ies) available for fluorexon and glycine
| Article | Year |
|---|---|
[A method for morphometry of bone formation using fluorochromes (author's transl)].
Topics: Animals; Bone and Bones; Bone Regeneration; Fluoresceins; Fluorescent Dyes; Glycine; Microscopy, Fluorescence; Phenols; Rabbits; Rats; Sulfoxides; Xylenes | 1980 |
Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
Topics: Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Deferoxamine; Erythrocytes; Ethylenediamines; Ferrous Compounds; Fluoresceins; Fluorescent Dyes; Glycine; Humans; Iron Chelating Agents; Liver; Malaria, Falciparum; Mice; Microscopy, Fluorescence; Parasitemia; Plasmodium falciparum; Plasmodium yoelii; Prodrugs; Quaternary Ammonium Compounds; Razoxane; Spectrometry, Fluorescence; Surface Properties | 1999 |
Dexrazoxane (ICRF-187) protects cardiac myocytes against hypoxia-reoxygenation damage.
Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Ethylenediamines; Extracorporeal Membrane Oxygenation; Fluoresceins; Fluorescent Dyes; Glycine; Hypoxia; Ion Transport; L-Lactate Dehydrogenase; Models, Cardiovascular; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Razoxane; Time Factors; Treatment Failure | 2002 |
The doxorubicin-cardioprotective drug dexrazoxane undergoes metabolism in the rat to its metal ion-chelating form ADR-925.
Topics: Animals; Biotransformation; Cardiovascular Agents; Chelating Agents; Chromatography, High Pressure Liquid; Ethylenediamines; Fluoresceins; Glycine; Half-Life; Indicators and Reagents; Infusions, Intravenous; Iron; Male; Molecular Structure; Rats; Rats, Sprague-Dawley; Razoxane | 2002 |
Novel long-circulating liposomes containing peptide library-lipid conjugates: synthesis and in vivo behavior.
Topics: Animals; beta-Alanine; Biodegradation, Environmental; Delayed-Action Preparations; Fluoresceins; gamma-Aminobutyric Acid; Glycine; Half-Life; Injections, Intravenous; Liposomes; Male; Peptide Library; Peptides; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Stearic Acids; Time Factors | 2004 |
Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Aniline Compounds; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cryoelectron Microscopy; Delayed-Action Preparations; Diynes; Doxorubicin; Drug Stability; Endocytosis; Female; Fluoresceins; Glycine; Gold; Humans; Imino Acids; Lasers; Liposomes; Lysophospholipids; Metal Nanoparticles; Organotechnetium Compounds; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polymers; Surface Plasmon Resonance | 2011 |